Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership.
Snyder RA, Burtness B, Cho M, Del Rivero J, Doroshow DB, Hitchcock KE, Kalyan A, Kim CA, Lukovic J, Parikh AR, Sanford NN, Singh B, Shen C, Shroff RT, Vijayvergia N, Goodman KA, Kunz PL. Snyder RA, et al. Among authors: kunz pl. J Natl Cancer Inst. 2023 Oct 9;115(10):1132-1138. doi: 10.1093/jnci/djad121. J Natl Cancer Inst. 2023. PMID: 37364007 Free PMC article.
A 46-Year-Old Woman With Chronic Dyspnea and Diarrhea.
Kshattry S, White M, Tchack J, Laskin W, Kunz PL. Kshattry S, et al. Among authors: kunz pl. Chest. 2023 Jan;163(1):e23-e29. doi: 10.1016/j.chest.2022.08.2214. Chest. 2023. PMID: 36628681
Correction to: PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly.
O'Toole D, Kunz PL, Webb SM, Goldstein G, Khawaja S, McDonnell M, Boiziau S, Gueguen D, Houchard A, Ribeiro-Oliveira A Jr, Prebtani A. O'Toole D, et al. Among authors: kunz pl. Adv Ther. 2024 Mar 13. doi: 10.1007/s12325-024-02829-6. Online ahead of print. Adv Ther. 2024. PMID: 38480663 No abstract available.
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.
Del Rivero J, Perez K, Kennedy EB, Mittra ES, Vijayvergia N, Arshad J, Basu S, Chauhan A, Dasari AN, Bellizzi AM, Gangi A, Grady E, Howe JR, Ivanidze J, Lewis M, Mailman J, Raj N, Soares HP, Soulen MC, White SB, Chan JA, Kunz PL, Singh S, Halfdanarson TR, Strosberg JR, Bergsland EK. Del Rivero J, et al. Among authors: kunz pl. J Clin Oncol. 2023 Nov 10;41(32):5049-5067. doi: 10.1200/JCO.23.01529. Epub 2023 Sep 29. J Clin Oncol. 2023. PMID: 37774329
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.
Singh S, Hope TA, Bergsland EB, Bodei L, Bushnell DL, Chan JA, Chasen BR, Chauhan A, Das S, Dasari A, Del Rivero J, El-Haddad G, Goodman KA, Halperin DM, Lewis MA, Lindwasser OW, Myrehaug S, Raj NP, Reidy-Lagunes DL, Soares HP, Strosberg JR, Kohn EC, Kunz PL; NET CTPM participants. Singh S, et al. Among authors: kunz pl. J Natl Cancer Inst. 2023 Sep 7;115(9):1001-1010. doi: 10.1093/jnci/djad096. J Natl Cancer Inst. 2023. PMID: 37255328
PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly.
O'Toole D, Kunz PL, Webb SM, Goldstein G, Khawaja S, McDonnell M, Boiziau S, Gueguen D, Houchard A, Ribeiro-Oliveira A Jr, Prebtani A. O'Toole D, et al. Among authors: kunz pl. Adv Ther. 2023 Feb;40(2):671-690. doi: 10.1007/s12325-022-02360-6. Epub 2022 Dec 11. Adv Ther. 2023. PMID: 36502449 Free PMC article.
Where Are All the Women in Industry Advisory Boards?
Shroff RT, Goodman KA, Mehnert JM, Vose JM, Moran SE, Yessaian JL, Baldo L, Alexander BM, Highsmith QB, Mills JM, Kunz PL. Shroff RT, et al. Among authors: kunz pl. J Clin Oncol. 2023 Mar 20;41(9):1659-1663. doi: 10.1200/JCO.21.02219. Epub 2022 Nov 3. J Clin Oncol. 2023. PMID: 36331246 No abstract available.
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161.
Rajdev L, Lee JW, Libutti SK, Benson AB, Fisher GA Jr, Kunz PL, Hendifar AE, Catalano P, O'Dwyer PJ. Rajdev L, et al. Among authors: kunz pl. Invest New Drugs. 2022 Dec;40(6):1306-1314. doi: 10.1007/s10637-022-01311-w. Epub 2022 Oct 20. Invest New Drugs. 2022. PMID: 36264382 Free PMC article. Clinical Trial.
83 results